Fintech PR
Legal Barriers Falling for the Cannabis Market’s Rampant Growth
Reading Time: 6 minutes
The cannabis market has begun to garner worldwide attention as more countries move to adopt cannabis legislation. Primarily, most countries are looking to adopt medical cannabis laws. Countries that have adopted medical legislation are leveraging cannabis to treat certain medical applications such as cancer, chronic pain, epilepsy, Alzheimer’s, and Parkinson’s disease. Throughout the past year, the cannabis industry has made significant milestones as the U.S. Food and Drug Administration approved its first cannabis-derived drug to treat epilepsy in children. Shortly after, the U.S. Drug Enforcement Agency removed CBD, or cannabidiol, off the Schedule 1 list. CBD-based products that have less than 0.1% THC concentrate will now be considered a Schedule 5 drug, as long as the medication has been approved by the FDA. Furthermore, the FDA recently scheduled a public hearing to be held in May as the agency looks to legalize CBD in food and drinks. The combination of these events has led to the exponential growth of the overall cannabis market. Moreover, as legalization efforts continue, other countries are expected to be influenced and potentially follow in legalizing cannabis. According to data compiled by Grand View Research, the global legal marijuana market was valued at USD 9.3 Billion and is expected to reach USD 146.4 Billion by the end of 2025. Additionally, the market is projected to register a CAGR of 34.6%. CLS Holdings, USA Inc. (OTC: CLSH) (CSE: CLSH.U), Charlotte’s Web Holdings, Inc. (OTC: CWBHF) (CSE: CWEB), Cresco Labs Inc. (OTC: CRLBF) (CSE: CL), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT)
Research and studies conducted within the cannabis industry have helped in adding credibility to the plant. However, the FDA ruled that due to the lack of large-scale and efficient clinical trials, the agency cannot approve cannabis as a registered treatment, yet. Now, researchers and companies involved within the industry are expanding their studies to help expand the cannabis market further. The FDA’s concern over cannabis becoming a legitimate medicine alternative signals the steps the market has taken. Decades ago, cannabis was internationally illegal. Now, countries including Australia, Canada, Columbia, Germany, the Netherlands, Spain, and the U.S. have all adopted cannabis legislation of some form. Moving forward, as more governments and regulatory agencies focus on the topic of cannabis legalization, the cannabis industry can become the next emerging global market. “It’s critical that we address these unanswered questions about CBD and other cannabis and cannabis-derived products to help inform the FDA’s regulatory oversight of these products — especially as the agency considers whether it could be appropriate to exercise its authority to allow the use of CBD in dietary supplements and other foods,” outgoing FDA Commissioner Scott Gottlieb recently said in a statement.
CLS Holdings, USA Inc. (OTCQB: CLSH) (CSE: CLSH.U) is also listed on the Canadian Securities Exchange under the ticker (CSE: CLSH.U). Earlier last week, the Company announced that, “since acquiring Oasis Cannabis Dispensary in Las Vegas, Nevada, CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE: CLSH.U) has been working to elevate the entire customer experience behind cannabis. The catchphrase “New Oasis, Same Faces” assures customers that they will still receive the same care and attention they’ve come to expect from Oasis Cannabis, only now in a totally redesigned, modern, and fresh facility. The new space is more accessible, inviting and vibrant, with the same friendly and knowledgeable staff. Over the past few months, walls have been torn down and the color scheme have been modernized from lime green to bright white with blue accents, evoking a vibrant and calming feel. LED lit display cases are purposefully and openly situated, allowing customers ample room to explore products. The large white bud bar hosts the budtender, who is able to curate a better user experience through education and a diverse product selection. At the heart of the renovation is improving customer experience – but the company’s dedication to education, compassionate care, and community enrichment remain the same.
All are welcome to join the Oasis Cannabis Grand Reopening Party, which will take place at the dispensary on Saturday April 6th 2019 from 12:00pm – 10:00pm. The event will feature vendors on-site, live art, live music, food trucks, and special prices. The dispensary is located at 1800 Industrial Rd #180, Las Vegas, NV 89102.
About Oasis Cannabis: Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In February 2019, it was named “Best Dispensary for Pot Pros” by Desert Companion Magazine.
In August 2017, the company commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products. http://oasiscannabis.com
About City Trees: Founded in 2017, City Trees is a Nevada based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees is one the fastest growing wholesale companies in the industry. Its products are now available at 40 dispensaries. https://citytrees.com
About CLS Holdings USA, Inc: CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states. CLS stands for “Cannabis Life Sciences,” in recognition of the Company’s patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company’s business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.”
For our latest “Buzz on the Street” Show featuring CLS Holdings, USA Inc. recent corporate news, please head over to:
Charlotte’s Web Holdings, Inc. (OTCQX: CWBHF) (CSE: CWEB) is the market leader in the production and distribution of innovative hemp-based cannabidiol wellness products. Recently, Charlotte’s Web Holdings, Inc. surpassed 3,000 retail locations across the United States. At the end of 2017, Charlotte’s Web products were sold in approximately 2,000 locations. The Company had recently that it surpassed its 2018 year-end goal of 3,000 locations during the 3rd quarter. With CBD gaining mainstream market momentum, Charlotte’s Web, the industry pioneer and category leader in hemp-based CBD, has expanded its suite of product offerings across a wider variety of retailers, from small specialty health food stores to now including regional pharmacy and grocery chains. “Firstly, I would like to commend our incredible and committed staff who worked tirelessly to achieve this milestone,” stated Charlotte’s Web Chief Executive Officer Hess Moallem. “I would also like to thank our dedicated retail partners for their continued support of our mission and for valuing the trust that is closely associated with our brand name.”
Cresco Labs Inc. (OTCQX: CRLBF) (CSE: CL) and CannaRoyalty Corp. d/b/a Origin House (CSE: OH) (OTCQX: ORHOF) recently announced that they have entered into a definitive agreement, pursuant to which Cresco Labs will acquire all of the issued and outstanding shares of Origin House. Under the terms of the Agreement, holders of common shares of Origin House will receive 0.8428 subordinate voting shares of Cresco Labs for each Origin House Share. Origin House has become a leading distributor and provider of brand support services in California, the world’s largest regulated cannabis market. Origin House’s proven strategy has been to build relationships with established dispensaries, build partnerships with established market-leading brands, develop promising cannabis product companies, and then leverage its full suite of support services to transform those products into strong California consumer brands. Origin House delivers over 50+ cannabis brands to more than 500 dispensaries in California, representing approximately 60% market penetration. “The acquisition of Origin House is another example of our focused and disciplined approach to creating a meaningful presence in key cannabis markets through excellence in brand development and distribution,” said Cresco Labs Chief Executive Officer and Co-founder Charlie Bachtell.
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) is the leader in pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. Zynerba Pharmaceuticals, Inc. recently announced that it has initiated the Phase 2 BRIGHT (An Open-Label Tolerability and Efficacy Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents with Autism Spectrum Disorder) trial. The trial will assess the safety, tolerability and efficacy of Zygel (previously referred to as ZYN002) for the treatment of child and adolescent patients with Autism Spectrum Disorder (ASD). The Company expects to present topline data from this study in the first half of 2020. Clinical and anecdotal data suggest that CBD may modulate the EC system and improve certain core social and behavioral autism-related symptoms, including social avoidance and anxiety. “Autism spectrum disorder can have a devastating impact on a child and their family,” said Armando Anido, Chairman and Chief Executive Officer of Zynerba. “The medical need is significant and unmet despite high awareness and advocacy efforts. Though there has been an accelerating rate of diagnosis, to date there are only two FDA approved products indicated for the treatment of ASD symptoms.”
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) specializes in the extraction, purification and formulation of health and wellness products. Neptune Wellness Solutions Inc. recently announced that it had completed its initial commercial production lots and is now shipping cannabis extracts from its licensed, GPP facility in Sherbrooke, Quebec. “The quality of the extracts in Neptune’s first production runs at our state-of-the-art facility has been terrific, and we are proud to begin deliveries. This marks an important step forward in the execution of our vision to lever our decades of extraction and wellness industry experience towards becoming the world’s leader in the extraction, purification and formulation of value-added, differentiated cannabis products,” said Jim Hamilton, President and Chief Executive Officer of Neptune.
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
SOURCE FinancialBuzz.com
Issued on behalf of Lake Victoria Gold Ltd.
VANCOUVER, BC, April 24, 2025 /PRNewswire/ — Equity Insider News Commentary – Amid the ongoing volatility on the markets, several gold stocks are surging, with the Top 50 mining companies thriving within the tariff-related chaos. All the while, analysts still believe these gold stocks are not only outperforming the market, but still look undervalued, a sentiment echoed by prominent economist Peter Schiff. Currently there are multiple mining companies making headlines with their recent developments, including Lake Victoria Gold (TSXV: LVG) (OTCQB: LVGLF), Barrick Gold Corporation (NYSE: GOLD) (TSX: ABX), NOVAGOLD Resources Inc. (NYSE-American: NG) (TSX: NG), Dynacor Group Inc. (TSX: DNG) (OTCPK: DNGDF), and Cabral Gold Inc. (TSXV: CBR) (OTCPK: CBGZF).
Gold is on a historic run, becoming what Barron’s is calling a “light in the investment darkness“, pointing to surging demand among not just bankers, but individuals seeking gold bars and coins alike. By the end of the year, Goldman Sachs’ analysts note that gold could not only finish over US$3,700/oz, but potentially even rise to as much as $4,000/oz by mid-2026.
Lake Victoria Gold (TSXV: LVG) (OTCQB: LVGLF) announced today that it’s evaluating a small-scale development opportunity aimed at generating early cash flow at its flagship Tembo Project in Tanzania to support its broader exploration strategy, following the recent conversion of its Prospecting License into four Mining Licenses (MLs). Through its local subsidiary MIPCCL, the company is in discussions to form a joint venture with the operator of a privately commissioned CIP processing facility situated within one of Tembo’s 4 MLs.
“This potential partnership could represent a unique opportunity to establish early, low-capital-cost production from Tembo while continuing to unlock the district’s exploration upside,” said Marc Cernovitch, President and CEO of Lake Victoria Gold. “We remain committed to advancing Tembo through both strategic exploration and disciplined project development.”
This initiative is at a preliminary, conceptual stage and is not based on a current mineral resource estimate, nor is it supported by a Feasibility Study that would demonstrate economic or technical viability. Any potential development remains highly speculative and subject to significant technical and economic uncertainties, including grade continuity, metallurgy, permitting, and financing.
“Tembo has always stood out as a project with the potential to deliver both near-term value and long-term discovery upside,” said Simon Benstead, Chairman and CFO of Lake Victoria Gold. “Evaluating this small-scale development opportunity allows us to test the system, generate operational insights, and potentially self-fund ongoing exploration. We believe this approach aligns well with our disciplined strategy and our commitment to responsible, phased development in Tanzania.”
Over the past year, LVG has made steady progress advancing its dual-asset strategy in the Lake Victoria Goldfield, one of East Africa’s most prospective and historically productive gold regions. The company believes it now has many of the key regulatory, financial, and operational components in place to support a transition from exploration toward phased development—creating both near- and long-term opportunities.
Tembo remains the company’s long-range flagship. Located immediately adjacent to Barrick Gold’s Bulyanhulu Mine, the 100%-owned project has seen over US$28 million in historical exploration investment, including more than 50,000 meters of drilling.
Results from targets like Ngula 1, Nyakagwe Village, and Nyakagwe East have identified multiple mineralized structures with high-grade gold intercepts, many of which remain open along strike and at depth. The company is now updating its view of the near-surface potential across those zones in light of its new mining licenses and improving local infrastructure.
While Tembo may be the larger prize, the Imwelo Project is likely to lead development. LVG acquired full control of Imwelo earlier this year, and the project already holds a valid Mining License and permits from the Government of Tanzania to move towards development.
Located west of AngloGold Ashanti’s Geita Gold Mine, Imwelo was previously the subject of an updated pre-feasibility study in 2021 and is now positioned as the company’s near-term development candidate. Early-stage development from Imwelo, if successfully advanced, could support ongoing work at Tembo while establishing a local operating presence.
Financially, LVG continues to pursue multiple avenues of support. In late 2024, the company signed a non-binding gold prepay term sheet with Monetary Metals—a U.S.-based gold finance firm—for up to 7,000 ounces of gold, subject to conditions precedent. Based on prevailing gold prices, that facility could potentially provide upwards of US$20 million in non-dilutive capital for construction costs.
In addition, LVG completed the first tranche of a three-stage strategic investment agreement with Taifa Group, Tanzania’s largest mining contractor. The initial C$3.52 million tranche closed in February at a share price of C$0.22.
As part of that relationship, Richard Reynolds, former CEO of Taifa Mining, was appointed to the company’s board—adding regional and operational depth at the governance level.
LVG also retains exposure to future upside through its 2021 deal with Barrick, which saw the company sell six non-core licenses adjacent to Tembo for US$6 million upfront, with up to US$45 million in contingent milestone payments tied to future discoveries. Barrick has been actively drilling on the package since, while LVG retains a back-end interest with no further capital outlay.
With early-stage development potential at Tembo, near-term development at Imwelo, and continued exposure to upside through its Barrick deal, Lake Victoria Gold is increasingly well-positioned within the East African junior gold sector.
CONTINUED… Read this and more news for Lake Victoria Gold at:
https://equity-insider.com/2025/04/14/with-funding-commitments-in-place-a-gold-mine-is-being-built-and-this-stock-is-still-under-0-20/
In other industry developments and happenings in the market include:
Barrick Gold Corporation (NYSE: GOLD) (TSX: ABX) is selling its 50% interest in the Donlin Gold Project to Paulson Advisers and NOVAGOLD Resources Inc. (NYSE-American: NG) (TSX: NG) in a $1 billion cash deal, with NOVAGOLD increasing its stake to 60% and Paulson acquiring 40%.
“The Donlin agreement allows Barrick to exit the Donlin Gold Project at an attractive valuation, while allowing NOVAGOLD and Paulson to pursue the development of the project,” said Mark Bristow, President and CEO of Barrick. “This is a good example of an instance where an asset we own might be better suited in the hands of others, while we pursue our priority portfolio of Barrick-managed growth projects.”
The transaction is expected to close in Q2 or Q3 2025, pending regulatory approvals. Under the new structure, NOVAGOLD and Paulson will share governance and management responsibilities for Donlin Gold.
“With 39 million ounces of gold at double the industry average grade, and an optimal location in the prime jurisdiction of Alaska — already the second largest gold-producing state in the United States — we believe that the project could create value for decades to come,” said John Paulson, head of private investment firm Pauslon Advisers, and Chairman of NOVAGOLD. “. Enjoying excellent social license and formidable exploration upside potential to significantly expand its resources and production profile, Donlin Gold constitutes a superb opportunity for us to gain leverage to gold in the United States at an attractive valuation.”
Their joint focus will be updating the project’s Feasibility Study, expanding drill programs, and maintaining environmental and community stewardship in Alaska’s Yukon-Kuskokwim region.
Dynacor Group Inc. (TSX: DNG) (OTCPK: DNGDF) achieved record gold sales of $80.0 million in Q1 2025, up 18.2% from the same period in 2024. March sales reached $28.8 million, boosted by a 38% increase in gold price year-over-year.
The company’s Veta Dorada plant continued operating at full capacity, processing 15,000 tonnes of ore. With gold averaging $2,878 per ounce year-to-date, Dynacor remains on target to hit its 2025 sales guidance of $345–$375 million.
Cabral Gold Inc. (TSXV: CBR) (OTCPK: CBGZF) recently returned one of its strongest drill results to date, intersecting 12m @ 27.7 g/t gold (including 5m @ 65.5 g/t) from 42m depth at the Machichie NE target in the Cuiú Cuiú gold district. This new result, combined with past high-grade hits, confirms a mineralized zone extending at least 200m along strike, which remains open at depth and laterally.
“These results from RC520 (12m @ 27.7 g/t gold) are amongst the best drill results we have ever received from any target at Cuiú Cuiú, and are further confirmation that a significant zone of bonanza-grade gold mineralization exists at Machichie NE,” said Alan Carter, President and CEO of Cabral. “We will continue to aggressively explore the 50+ targets at Cuiú Cuiú where we have gold in boulder fields, trenches and drill holes, whilst advancing our starter gold-in-oxide project which is targeting gold-in-oxide saprolite material. Given the plethora of high-grade values at numerous other targets at Cuiú Cuiú, we expect to make further high-grade discoveries similar to Machichie NE.”
Machichie NE sits just 150m from the Machichie Main discovery and 650m north of the MG gold deposit. Cabral is currently drilling multiple targets in the area while advancing its gold-in-oxide starter project and updating the broader resource model.
Article Source: https://equity-insider.com/2025/04/14/with-funding-commitments-in-place-a-gold-mine-is-being-built-and-this-stock-is-still-under-0-20/
CONTACT:
Equity Insider
info@equity-insider.com
(604) 265-2873
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Equity Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). This article is being distributed for Baystreet.ca media corp, who has been paid a fee for an advertising from a shareholder of the Company (333,333 unrestricted shares). MIQ has not been paid a fee for Lake Victoria Gold Ltd. advertising or digital media, but the owner/operators of MIQ also co-owns Baystreet.ca Media Corp. (“BAY”) There may also be 3rd parties who may have shares of Lake Victoria Gold Ltd. and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ/BAY own shares of Lake Victoria Gold Ltd and reserve the right to buy and sell, and will buy and sell shares of Lake Victoria Gold Ltd. at any time without any further notice commencing immediately and ongoing. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material, including this article, which is disseminated by MIQ on behalf of BAY has been approved by Lake Victoria Gold Ltd. Technical information relating to Lake Victoria Gold Ltd. has been reviewed and approved by David Scott, Pr. Sci. Nat., a Qualified Person as defined by National Instrument 43-101. Mr. Scott is a registered member of the South African Council for Natural Scientific Professions (SACNASP) and is a Director of Lake Victoria Gold Ltd., and therefore is not independent of the Company; this is a paid advertisement, we currently own shares of Lake Victoria Gold Ltd. and will buy and sell shares of the company in the open market, or through private placements, and/or other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
Logo – https://mma.prnewswire.com/media/2644233/5285411/Equity_Insider_Logo.jpg
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/gold-stocks-are-quietly-outperforming-the-rest-of-the-market-302437445.html
Fintech PR
Aily Labs Expands Board and Advisory Board with AI and Industry Heavyweights to Accelerate Agentic AI Adoption Across the Fortune 500
- Aily Labs welcomes Amy Chang, a technology visionary and current board member of Disney and Procter & Gamble, to its Board of Directors and Advisory Board, bringing exceptional innovation and technology-scaling leadership
- Joseph Jimenez, Co-Founder and Managing Director of Aditum Bio and former CEO of Novartis, joins Advisory Board offering deep executive leadership expertise in pharmaceutical and CPG
- Derica Rice, former EVP of CVS Health, President of CVS Caremark, and CFO of Eli Lilly joins Advisory Board to guide AI adoption across healthcare, CPG, retail, and more
- Chang, Jimenez, and Rice’s appointments reinforce Aily Labs’ mission to reshape how the world’s most influential companies apply agentic AI at scale for decision-making
NEW YORK, April 24, 2025 /PRNewswire/ — Aily Labs GmbH, pioneer of the first-and-only AI-native Decision Intelligence App for global enterprises, today announced the appointment of Amy Chang to its Board of Directors and Advisory Board and Joseph Jimenez and Derica Rice to its Advisory Board. These appointments mark a bold inflection point as Aily Labs scales its platform globally — powered by an always-on, agentic AI suite, including a new autonomous AI agent designed to deliver forward-thinking, personalized recommendations to corporate leaders — to help enterprises move faster, operate more sharply, and stay ahead.
“Amy, Joe, and Derica are exceptional enterprise business leaders and transformational role models. Welcoming them to Aily Labs exemplifies our shared commitment to build a new category of AI-first decision intelligence for Fortune 500 leaders,” said Bianca Anghelina, Founder and CEO of Aily Labs. “Together, we’re not just augmenting decisions, we’re reshaping how the world’s most influential companies apply AI at scale for decision making.”
Amy Chang Appointed to Aily Labs’ Board of Directors and Advisory Board
Ms. Chang serves on the Boards of Disney and Procter & Gamble (P&G), bringing a proven track record in digital transformation, product innovation, and scaling high-growth technology companies. She was the founder and CEO of Accompany, Inc., acquired by Cisco, where she later led its multi-billion-dollar Collaboration business. Previously, she held board roles at Cisco, Splunk, Informatica, and Marqeta — representing nearly $1 trillion in combined market capitalization.
“It’s an incredibly exciting time to be advising Aily Labs as they stand at the forefront of the AI revolution, transforming all facets of business from finance resource allocation to supply chain optimization – all of it with single-day integration for customers,” said Ms. Chang. “Aily Labs’ vision to shift enterprises from passive data to active, agent-driven action is bold, and I am thrilled to be part of this journey shaping the future of work with agentic AI.”
Joseph Jimenez Appointed to Aily Labs’ Advisory Board
Mr. Jimenez brings decades of executive leadership and healthcare innovation, advising on strategic growth across industries. He currently serves as Co-Founder and Managing Director of Aditum Bio, sits on the Boards of P&G and General Motors, and previously served as the CEO of Novartis.
“As CEO of Novartis, I made capital allocation decisions across dozens of business units. In pharma and biotech, speed and precision save lives. Aily Labs is applying that same urgency and accuracy to enterprise decision-making, using agentic AI to drive faster, smarter outcomes,” said Mr. Jimenez. “This is the AI platform every leadership team needs.”
Derica Rice Appointed to Aily Labs’ Advisory Board
Mr. Rice, former EVP of CVS Health and President of CVS Caremark, brings extensive experience from senior roles in healthcare and finance. Previously at Eli Lilly, he served as EVP and Chief Financial Officer, helping shape long-term corporate strategy. He currently serves on the Boards of Disney, Target, Bristol Myers Squibb, and The Carlyle Group.
“Aily Labs is unlocking a new level of enterprise productivity, enabling people and AI agents to work seamlessly together, eliminate inefficiencies, and act with precision,” said Mr. Rice. “I’m excited to support the scaling of AI decision intelligence across industries, where it has the potential to transform how leaders operate, prioritize, and deliver impact at speed.”
Aily Labs
Aily Labs transforms business needs into applied AI use cases, embedding them into an easy-to-integrate, simple-to-use app. Its AI-powered platform and AI agent suite combine the latest advancements in large language models and business data with AI decision intelligence to supercharge enterprises with real-time insights and actionable data. This intuitive platform enables Fortune 500 organizations to achieve unmatched efficiency, drive innovation, and fuel unstoppable growth.
Founded in 2020, Aily Labs is an AI Software company and on a mission to transform ways of working by empowering businesses with meaningful AI. Aily Labs accelerates the digital journeys of large, global organizations, supported by an experienced team of digital specialists and data scientists. For more information, visit ailylabs.com.
Aily Labs Contact
Ken Huang
Ken.Huang@AilyLabs.com
Jessica Muldoon
AilyLabs@ruderfinn.com
Logo – https://mma.prnewswire.com/media/2417466/Aily_Labs_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/aily-labs-expands-board-and-advisory-board-with-ai-and-industry-heavyweights-to-accelerate-agentic-ai-adoption-across-the-fortune-500-302437313.html
SYDNEY, April 24, 2025 /PRNewswire/ — Integrated Research (IR) (ASX:IRI), the world’s most trusted independent provider of observability for business-critical IT ecosystems, today announced that a top 10 global bank has deployed IR’s High Value Payments solution to enable real-time visibility and control across its high value payments environment.
This deployment marks a significant milestone in IR’s growing role in supporting global financial institutions to reduce risk, meet rising regulatory demands, and modernize complex payments systems.
The bank turned to IR to strengthen end-to-end oversight of the hundreds of thousands of high value transactions it processes daily across payment systems including Fedwire, SWIFT and CHIPS. By monitoring payment queues, system performance, and transaction flows in real time, the institution can proactively anticipate issues, minimize delays, and strengthen compliance and liquidity risk management.
“Efficiently processing high value payments is critical to the success of the global financial system – when those transactions are delayed or non-compliant, the consequences are serious,” said Ian Lowe, CEO at IR. “As a top 10 global bank, this client needed more than just monitoring. They needed real-time, actionable insight from origination to settlement across every major clearing network to mitigate risk, stay compliant, and protect their operations. That’s what they get with IR.”
IR will be attending the Nacha Smarter Faster Payments conference in New Orleans from April 27 – 30. Visit booth 1054 for a demo of the High Value Payments solution and discover how IR supports mission-critical payments environments for financial leaders worldwide. Or visit ir.com to find out more.
About Integrated Research (IR)
Integrated Research (IR) is the world’s most trusted independent provider of observability solutions for critical IT infrastructure, payments and communications ecosystems.
IR’s Prognosis platform provides the visibility and insight organizations need to optimize performance of their business-critical technology, deliver exceptional user experiences and drive growth through innovation.
Discover better with IR.
Logo – https://mma.prnewswire.com/media/1538708/Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/top-10-bank-chooses-ir-to-power-high-value-payments-intelligence-302436694.html
-
Fintech PR5 days agoBybit’s CEO Meets with Vietnam’s Minister of Finance to Support Regulatory Sandbox and Strengthen Crypto Compliance
-
Fintech PR7 days agoDigital Oilfield Market is expected to generate a revenue of USD 38.09 Billion by 2031, Globally, at 5.31% CAGR: Verified Market Research®
-
Fintech PR6 days agoYarbo Secures $27M+ Series B Funding to Accelerate Global Growth, Innovation, and Ecosystem Expansion
-
Fintech PR6 days agoeCig Click Questions Impact of £10 Million Trading Standards Crackdown on Illicit Tobacco and Vaping Trade
-
Fintech PR7 days agoCognoa Advocates for Expanded Insurance Coverage of Canvas Dx as CDC Reports 1 in 31 Children Now Identified with Autism
-
Fintech PR5 days ago“Shanghai Summer”: A Living Case of a Next-Generation Consumer Hub
-
Fintech PR7 days agoCard Payments Market to Reach $38,325.4 billion by 2027 in the short run and $56,379.3 billion by 2033 Globally, at 6.9% CAGR: Allied Market Research
-
Fintech PR5 days agoShanghai Summer: A One-of-a-Kind Seasonal Experience